Cross-linked Emulsion Study
NCT01333020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2012-06-22
Summary
This comparative pilot study is designed to compare the rates of gastric emptying and by inference rates of digestion of two food emulsions. Two types of milk protein stabilised food emulsion will be compared, one standard emulsion preparation and one emulsion preparation cross-linked with microbial transglutaminase. The information from this study will then be compared to data on satiety and endocrine hormones from a parallel study undertaken in Finland using the same two meal formulations. The drinks will be labeled with a stable isotope of carbon and samples of breath collected every 20 minutes after consumption of the drink. This will allow gastric residence time to be calculated. The pilot will also fulfill two secondary objectives. At the same time as the breath samples are collected MRI scans of the upper abdomen will be made so that gastric volumes can be measured in order to compare the two methods of measuring gastric emptying rates. Additionally, samples of saliva will also be collected after every MRI scan for subsequent mass spectrometry analysis. These are to assess the efficacy of mass spectrometry analysis for detection of the presence of specific digestion related hormones such as ghrelin.
Conditions
- Healthy Volunteers
Interventions
- OTHER
-
cross-linking of an emulsion drink
This study will assess whether a subtle change in food structure (cross-linking of interfacial protein) can alter gastric emptying rate.
Sponsors & Collaborators
-
Norfolk and Norwich University Hospitals NHS Foundation Trust
collaborator OTHER -
Quadram Institute Bioscience
lead OTHER
Principal Investigators
-
Alan R Mackie, PhD · Quadram Institute Bioscience
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.
NCT02381769 ·Status: COMPLETED ·Phase: NA
-
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding
NCT05112328 ·Status: RECRUITING ·Phase: NA
-
The HOME Study (HPN With OMEGA-3)
NCT03282955 ·Status: COMPLETED ·Phase: PHASE4
-
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NCT04227678 ·Status: RECRUITING ·Phase: NA
-
Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition
NCT04051840 ·Status: UNKNOWN ·Phase: PHASE1
-
Lipid Emulsions and Liver Function - Results After 5 Years.
NCT04347902 ·Status: COMPLETED ·Phase: PHASE4
-
Kinetic Study of Lp(a) and PCSK9 in Humans
NCT04247048 ·Status: COMPLETED ·Phase: NA
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4
-
Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical Outcomes
NCT03442361 ·Status: COMPLETED
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
Effect of Pancreatic Polypeptide on Gastric Motor Function and Food Intake in Humans
NCT03854708 ·Status: COMPLETED ·Phase: PHASE4
-
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
NCT00004347 ·Status: UNKNOWN ·Phase: PHASE2
-
Enteral Nutrition Product in Mild Acute Pancreatitis
NCT01249963 ·Status: UNKNOWN ·Phase: NA
-
Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
NCT01113567 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
NCT00826020 ·Status: COMPLETED ·Phase: PHASE2
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
NCT00004809 ·Status: COMPLETED ·Phase: PHASE1
-
SMOFLipid in Patients Who Are Intralipid Intolerant
NCT03054948 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073368 ·Status: COMPLETED ·Phase: NA
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube
NCT00999232 ·Status: COMPLETED ·Phase: PHASE4
-
A Strategy for Gallstone Expulsion Through Dietary Therapy
NCT06699030 ·Status: RECRUITING ·Phase: NA